Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment

Major advances in the treatment of multiple myeloma (MM) have been achieved by effective new agents such as proteasome inhibitors, immunomodulatory drugs, or monoclonal antibodies. Despite significant progress, MM remains still incurable and, recently, cellular immunotherapy has emerged as a promisi...

Descrición completa

Detalles Bibliográficos

Principais autores:	Son Hai Vu, Ha Hong Pham, Thao Thi Phuong Pham, Thanh Thien Le, Manh-Cuong Vo, Sung-Hoon Jung, Je-Jung Lee, Xuan-Hung Nguyen
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Oncology
Assuntos:	multiple myeloma chimeric antigen receptor adoptive NK cell therapy metabolic engineering banked cells clinical trials
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1275076/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!